FROM MOLECULE...TO HUMAN
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
Laboratory | Mass spectrometry
Small Molecules Analysis by Mass Spectrometry
is a platform dedicated to the absolute quantification of small molecules,
drugs, metabolites and biomarkers in biological fluids.
LeaderAlain PRUVOST33 1 69 08 13 email@example.com
Permanent staffAurélie Ghettas-Messager, TechnicianFrédéric Théodoro, Technician
This platform is implanted in the Pharmacology and Immunoanalysis unit (SPI); it comprises 5 liquid chromatography instruments together with mass spectrometers triple quadrupole analyzers (UPLC-MS/MS). SMArt-MS can access if needed to the high-resolution instruments of MetaboHUB platform. Human resources of the platform are composed of a CEA engineer, two CEA technicians and non-statutory personnel.
Our missions are:
SMArt-MS performs these activities for the Laboratory of Drug Metabolism Research (SPI), other CEA laboratories, LabEx LERMIT which SPI is part and external partners.
SMArt-MS present partners:
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.